Ming-Mo Hou
Impact in
-
- Cancer Immunotherapy and Biomarkers
-
- Ovarian cancer diagnosis and treatment
Papers in
-
- Lung Cancer Treatments and Mutations 5
- Lung Cancer Diagnosis and Treatment 2
- Oncology 6
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 1
- Co-authors
- Aung Naing (4 shared papers)Siqing Fu (4 shared papers)David S. Hong (4 shared papers)Filip Jankú (4 shared papers)Karen H. Lu (3 shared papers)Ralph Zinner (3 shared papers)Razelle Kurzrock (3 shared papers)Robert L. Coleman (2 shared papers)
- Journals
- Oncotarget (2 papers)Biomedical Journal (1 paper)The Oncologist (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)Targeted Oncology (1 paper)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Ming-Mo Hou
8 papers receiving 127 citations
Peers
Comparison fields: 5 of 36
- Oncology 52
- Reproductive Medicine 16
- Pulmonary and Respiratory Medicine 54
- Cancer Research 23
- Obstetrics and Gynecology 10
Countries citing papers authored by Ming-Mo Hou
This map shows the geographic impact of Ming-Mo Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Mo Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Mo Hou more than expected).
Fields of papers citing papers by Ming-Mo Hou
This network shows the impact of papers produced by Ming-Mo Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Mo Hou. The network helps show where Ming-Mo Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming-Mo Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 50 | |
| 2 | 2021 | 22 | |
| 3 | 2016 | 19 | |
| 4 | 2014 | 11 | |
| 5 | 2016 | 9 | |
| 6 | Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program. | 2014 | 9 |
| 7 | 2015 | 6 | |
| 8 | Erlotinib treatment in patients with advanced lung adenocarcinoma with CISH-positive and CISH-negative EGFR gene alterations. | 2012 | 3 |
| 9 | 2024 | 0 |
About Ming-Mo Hou
Ming-Mo Hou is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Pathology and Forensic Medicine and Molecular Biology, having authored 9 papers that have together received 129 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Cancer Mechanisms and Therapy (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Cancer Treatment and Pharmacology (1 paper), Medical Imaging Techniques and Applications (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (52 citations), Reproductive Medicine (16 citations), Pulmonary and Respiratory Medicine (54 citations), Cancer Research (23 citations) and Obstetrics and Gynecology (10 citations). Ming-Mo Hou has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Aung Naing, Siqing Fu, David S. Hong, Filip Jankú, Karen H. Lu, Ralph Zinner, Razelle Kurzrock, Robert L. Coleman, Jennifer J. Wheler and Apostolia M. Tsimberidou. Their work appears in journals such as Oncotarget, Biomedical Journal, The Oncologist, Cancer Chemotherapy and Pharmacology and Targeted Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.